A live-attenuated SARS-CoV-2 vaccine candidate with accessory protein deletions
2022 · Nature Communications · 96 citations
https://doi.org/10.1038/s41467-022-31930-z
S
Sivakumar Periasamy
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
79
Papers
1.3K
Citations
23
h-index
38
i10-index
Sivakumar Periasamy is an academic researcher from Galveston College. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & COVID-19 Clinical Research Studies & Bacillus and Francisella bacterial research. The author has an h-index of 23, co-authored 68 publications.
ORCID: 0000-0002-7038-5140Papers by this author
worksDevelopment of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2
2021 · Journal of Clinical Virology · 48 citations
https://doi.org/10.1016/j.jcv.2021.105024
Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition
2021 · Cell Reports · 28 citations
https://doi.org/10.1016/j.celrep.2021.109784
Pyrin-only protein 2 limits inflammation but improves protection against bacteria
2017 · Nature Communications · 20 citations
https://doi.org/10.1038/ncomms15564
Necroptotic debris including damaged mitochondria elicits sepsis-like syndrome during late-phase tularemia
2017 · Cell Death Discovery · 12 citations
https://doi.org/10.1038/cddiscovery.2017.56
A global collaboration for systematic analysis of broad-ranging antibodies against the SARS-CoV-2 spike protein
2025 · Cell Reports · 3 citations
https://doi.org/10.1016/j.celrep.2025.115499
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat